Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia
Clinical trial NCT05889156 · COMPLETED
Trial details
- NCT number
- NCT05889156
- Sponsor
- NorthSea Therapeutics B.V.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-30
- Primary completion
- 2025-03-18
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.